Scientific Program

September 26 (Thu)

Symposium 01

Inspector workshop of Korean laboratory accreditation program

Overview: This workshop deals with the accreditation checklist and intends to improve understanding and practical skills required to inspection team leader and team members

Date & Time Sept. 26 (Thu), 13:00-15:00 Venue 205 (2F) Language Korean
Chairs Seok Lae Chae, Dongguk University College of Medicine, Korea
Do Hoon Lee, National Cancer Center, Korea
Speakers
  1. 1.Role and responsibilities of inspection team leader
    JeongYeal Ahn, Gachon University Gil Hospital, Korea
  2. 2.Internal quality control in clinical microbiology
    Mi-Na Kim, University of Ulsan College of Medicine, Korea
  3. 3.Quality Control for Laboratory Developed Molecular Tests
    Jin Kyung Lee, Korea Cancer Center Hospital, Korea
  4. 4.Risk Management in the Clinical Laboratory
    Woo In Lee, Kyung Hee University School of Medicine, Korea

Symposium 02

KCDC-KSLM Session: National surveillance system for severe infection caused by unknown pathogens

Overview: TBD

Date & Time Sept. 26 (Thu), 13:00-14:40 Venue 201-202 (2F) Language Korean
Chairs Miae Lee, Ewha Womans University College of Medicine, Korea
TBD
Speakers
  1. 1.Current situation and need for surveillance of unknown cause of infectious diseases
    Hyukmin Lee, Yonsei University College of Medicine, Korea
  2. 2.Establishment of public-private diagnostic laboratory partnership for syndromic surveillance in Korea
    Seungman Park, Green Cross Laboratories, Korea
  3. 3.Laboratory Analysis System for unknown cause of infectious diseases
    Byung Hak Kang, Korea Centers for Disease Control and Prevention, Korea
  4. 4.Introduction for Response System for Unexplained Etiology Infectious Diseases Outbreak
    Eun Kyoung Kim, Korea Centers for Disease Control and Prevention, Korea

Symposium 03

Education Track

Overview: This session is intended for residents in training, new starters, or laboratory professionals with interests of basic knowledge. We will be covering the very basics and practical aspects of laboratory medicine in the fields of hematology, transfusion medicine, microbiology, and immunology.

Date & Time Sept. 26 (Thu), 15:00-17:00 Venue 205 (2F) Language Korean
Chairs Seung-Jung Kee, Chonnam National University Medical School, Korea
Namhee Ryoo, Keimyung University School of Medicine, Korea
Speakers
  1. 1.Korean Red Cross HLA-matched Platelets
    Yeongbin Kim, Korean Red Cross, Korea
  2. 2.The laboratory principle and clinical significance of the interferon-gamma releasing assay (IGRA)
    Soyoun Shin, The Korean Institute of Tuberculosis, Korea
  3. 3.Clinical Microbiology Testing for Multidrug Resistant Bacteria
    Jae-Seok Kim, Hallym University College of Medicine, Korea
  4. 4.Identify & Resolve Errors in automated cell counter
    Hye Ryoun Kim, Chung-Ang University College of Medicine, Korea

Symposium 04

Practical aspects of laboratory management (VI) ; Systematic Laboratory Management

Overview: The ‘Laboratory Management Committee’ will introduce Laboratory Ethics, Laboratory Setting Management, and Laboratory Tests Utilization Management, which are the basic elements for Systematic Laboratory Management.

Date & Time Sept. 26 (Thu), 15:00-16:40 Venue 201-202 (2F) Language Korean
Chairs Jong Hyun Yoon, Seoul National University College of Medicine, Korea
Hyung Hoi Kim, Pusan National University Hospital, Korea
Speakers
  1. 1.Laboratory ethics
    Sung Ran Cho, Ajou University School of Medicine, Korea
  2. 2.Laboratory setting management
    Minje Han, Kangdong Sacred Heart Hospital, Korea
  3. 3.Laboratory tests utilization management
    Yeo-Min Yun, Konkuk University School of Medicine, Korea

Plenary Lecture 01

Date & Time Sept. 26 (Thu), 17:30-18:30 Venue 205 (2F) Language English
Chair Jang Soo Suh, Kyungpook National University School of Medicine, Korea
Speaker
  1. Experience in developing bone marrow image analyzer for users
    Kyungja Han, The Catholic University of Korea College of Medicine, Korea

September 27 (Fri)

Keynote Speech 01

Date & Time Sept. 27 (Fri), 08:00-08:40 Venue 205 (2F) Language English
Chair Won-Ki Min, University of Ulsan College of Medicine, Korea
Speaker
  1. Next generation diagnostic probes for laboratory medicine
    Tahir Pillay, University of Pretoria, South Africa

Symposium 05

Advanced applications of lipid tests

Overview: This session will discuss some of the difficult challenges regarding lipid tests. The current status and challenges of standardization of the lipoprotein testing as a biomarker of cardiovascular disease is discussed. We will provide the clinical usefulness and utilization of nonfasting lipid profile, and the differences in triglyceride results according to whether free glycerol is blanked or not.

Date & Time Sept. 27 (Fri), 09:00-10:40 Venue 205 (2F) Language English
Chairs Jeong-Ho Kim, Yonsei University College of Medicine, Korea
Kyung Eun Song, Kyungpook National University School of Medicine, Korea
Speakers
  1. 1.Standardization of lipoprotein testing
    Vincent Delatour, Laboratoire National de Métrologie et d'Essais, France
  2. 2.Nonfasting lipid profiles- are we there yet?
    Khushbu Patel, UT Southwestern Medical Center, USA
  3. 3.Triglyceride test with or without free glycerol blanking
    Jinsook Lim, Chungnam National University Hospital, Korea

Symposium 06

POCT: Current status and the future

Overview: Point-of-care testing (POCT) is one of the most rapidly growing areas within laboratory medicine. POCT offers considerable advantages, and there are challenges associated with POCT. In this session, current and future of POCT will be presented by speakers from Asian countries. Various issues, experiences and future perspectives of POCT in Asian countries will be shared and discussed.

Date & Time Sept. 27 (Fri), 08:30-10:40 Venue 201-202 (2F) Language English
Chairs Namid Munkhtuvshin, Mongolia Association of Laboratory Medicine, Mongolia
Hwan Sub Lim, Seoul Clinical Laboratories, Korea
Speakers
  1. 1.POCT in india : Current Scenario and the road ahead
    Prasenjit Mitra, All India Institute of Medical Sciences, India
  2. 2.Past, Present and Future of Point of Care Testing in Thailand
    Nisarat Opartkiattikul, Thai Society of Clinical Pathology, Thailand
  3. 3.POCT : current status and future in Mongolia
    M. Oyundelger, Mongolian Association of the Laboratory Medicine, Mongolia
  4. 4.Practical challenges related to Point-of-care testing
    Nguyen Minh Ha, Nguyen Tri Phuong Hospital, Vietnam
  5. 5.POCT in Myanmar : Present and Future Prospects
    Wah Wah Aung, Ministry of Health and Sports, Myanmar
  6. 6.POCT in Taiwan : current and the future
    Po-Ren Hsueh, National Taiwan University College of Medicine, Taiwan
  7. 7.Present and Future of POCT in Korea
    Hyung-Doo Park, Sungkyunkwan University School of Medicine, Korea
  8. 8.Implementation POCT in Indonesia
    Luci Liana, Fatmawati Hospital, Indonesia

Symposium 07

MFDS-KSLM Session: Pre-market evaluation and Post-market safety management, Standard materials for laboratory and IVD manufacturer

Overview: In vitro diagnostic (IVD) devices are approved for manufacturing and importing by the Ministry of Food and Drug Safety (MFDS). Regarding post market safety management for distribution and use after the initial approval, the purpose is to provide safe and effective medical devices with follow-up management. The standard materials provided by the MFDS play an important role in product development and evaluation by domestic IVD manufacturing companies, and present unmet needs in laboratory.

Date & Time Sept. 27 (Fri), 08:40-10:40 Venue 203-204 (2F) Language Korean
Chairs Je Hoon Lee, The Catholic University of Korea Yeouido St. Mary's Hospital, Korea
Won-Kyu Lee, Division of In Vitro Diagnostic Devices, National Institute of Food and Drug Safety Evaluation, Korea
Speakers
  1. Session 1: Post market safety management for IVD and Standard materials from MFDS in laboratory
  2. 1.Adverse Events Management and the Reporting System for In-Vitro Diagnostic Medical Devices in Korea
    Segu Kang, Ministry of Food and Drug Safety, Korea
  3. 2.Experience in establishment of MFDS reference standards and their usage in laboratory
    Hee Jin Huh, Dongguk University College of Medicine, Korea
  4. 3.Experience of MFDS standard material and unmet need
    Hae Joon Park, SD Biosensor, Korea
  5. Session 2: IVD support program of MFDS
  6. 4.IVD Authorazation Process
    Seung-Rel Ryu, Ministry of Food and Drug Safety, Korea
  7. 5.Introduction of IVD Productification Support Program
    Ji Hun Cha, Ministry of Food and Drug Safety, Korea

Plenary Lecture 02: AACC-KSLM Select Session

Date & Time Sept. 27 (Fri), 11:00-12:00 Venue 205 (2F) Language English
Chair Gye Cheol Kwon, Chungnam National University College of Medicine, Korea
Speaker
  1. Immunoassay interferences and their impact on patient care
    Carmen L. Wiley, American Association for Clinical Chemistry, USA

Symposium 08

AACC-KSLM Select Session: Biomarkers of Alzheimer’s Disease: What’s new in 2019?

Overview: Alzheimer’s disease is a complex degenerative brain disease and the most common cause of dementia. Although no treatment is currently available, significant discovery efforts are underway. Diagnosis of Alzheimer’s disease is based on clinical features and supplemented by determination of biomarkers of Alzheimer’s disease pathology. In this session, an overview of Alzheimer’s disease will be provided, current and novel biomarkers will be presented. Considerations for the implementation of Alzheimer's disease biomarkers in the clinical laboratory and the application of biomarkers in the clinical practice will be discussed.

Date & Time Sept. 27 (Fri), 13:00-14:40 Venue 205 (2F) Language English
Chairs Eun Hee Lee, Green Cross Laboratories, Korea
Sail Chun, University of Ulsan College of Medicine, Korea
Speakers
  1. 1.Fluid and imaging biomarkers toward the development of therapies for Alzheimer's disease: experience from Japanese ADNI
    Takeshi Iwatsubo, The University of Tokyo, Japan
  2. 2.Pre-analytical and Analytical Considerations for the Implementation of AD biomarkers in the Clinical Laboratory
    Alicia Algeciras-Schimnich, Mayo Clinic, USA
  3. 3.Biomarkers of Alzheimer's disease
    Ae Young Lee, Department of Neurology, Chungnam National University College of Medicine, Korea

Symposium 09

Multiplex assays in the field of diagnostic immunology

Overview: We would like to share the recent applications of multiplex immunoassays to diagnose autoimmune and infectious diseases and to monitor cancer immunotherapy

Date & Time Sept. 27 (Fri), 13:00-14:40 Venue 201-202 (2F) Language English
Chairs Hyon-Suk Kim, Yonsei University College of Medicine, Korea
Eun Suk Kang, Sungkyunkwan University School of Medicine, Korea
Speakers
  1. 1.Multiplex assay application for the diagnosis of autoimmune disease
    Marvin Fritzler, University of Calgary, Canada
  2. 2.Soluble type immune regulatory molecule assays in the field of cancer immunotherapy
    Jong-Han Lee, Yonsei University Wonju College of Medicine, Korea
  3. 3.Multiplex Ag/Ab assay for the diagnosis of infectious diseases
    Jaehyeon Lee, Chonbuk National University Medical School, Korea

Symposium 10

Surveyor Training Program

Overview: Maintaining consistency in on-site inspection of clinical laboratories is of vital importance as the results of inspection may affect reimbursement fee in Korea. In this session, current status of surveyor training programs of ISQua, KOIHA, and LMF will be introduced and perspective in LMF will be discussed.

Date & Time Sept. 27 (Fri), 13:00-14:40 Venue 203-204 (2F) Language English
Chairs Myung-Hyun Nam, Korea University College of Medicine, Korea
Moon-Woo Seong, Seoul National University College of Medicine, Korea
Speakers
  1. 1.Accreditation of Surveyor Training Programme by the International Society for Quality in Health Care External Evaluation Association (IEEA)
    Lena Low, The Australian Council on Healthcare Standards, Australia
  2. 2.Management and Education for surveyors in Korea Institute for Healthcare Accreditation
    Hyun Ji Baek, Korea Institute for Healthcare Accreditation, Korea
  3. 3.Introduction of Inspector Training Program by LMF
    Jihyang Lim, The Catholic University of Korea, College of Medicine, Korea

Symposium 11

Laboratory Test Utilization and Quality Management in Laboratory Medicine after introduction of New DRG

Overview: TBD

Date & Time Sept. 27 (Fri), 13:00-14:40 Venue 101-102 (1F) Language Korean
Chairs Tae Hyun Um, Inje University Ilsan Paik Hospital, Korea
You Kyoung Lee, Soonchunhyang University Bucheon Hospital, Korea
Speakers
  1. 1.Comparing the perceptions and opinions of clinicians and laboratory medicine physicians about new DRG, laboratory test utilization and quality incentive
    Yong-jun Choi, Department of Social and Preventive Medicine, Hallym University College of Medicine, Korea
  2. 2.Comparison of laboratory test quality between laboratories with or without participating in New DRG: analysis of KEQAS data
    Sollip Kim, Inje University Ilsan Paik Hospital, Korea
  3. 3.Comparing the laboratory test utilization between non-participating and participating medical institute before and after the new DRG
    Hyeongsu Kim, Department of Preventive Medicine, School of Medicine, Konkuk University, Korea
  4. 4.Discussion
    Jae-Hyeok Heo, Department of Neurology, Seoul Medical Center, Korea
    Soo Hyun Hwang, Masan Medical Center, Korea
    Tae Hyun Um, Inje University Ilsan Paik Hospital, Korea
    Kunsei Lee, Department of Preventive Medicine, School of Medicine, Konkuk University, Korea
    Jin Seon Gong, Health Insurance Review & Assessment Service, Korea

Symposium 12

Transcriptomics as a new diagnostic tool

Overview: With the rapid development and application of next-generation sequencing in molecular genetics, RNA, as well as DNA, has become the main target of the NGS test. In this session, we will explore the principles and applications of RNA-Seq and discuss the possibilities as a clinical diagnostic tool.

Date & Time Sept. 27 (Fri), 15:00-16:40 Venue 205 (2F) Language English
Chairs Chang-Ho Jeon, Catholic University of Daegu School of Medicine, Korea
Jong-Won Kim, Sungkyunkwan University School of Medicine, Korea
Speakers
  1. 1.RNA sequencing in leukemia research
    Zhaolei Zhang, University of Toronto Faculty of Medicine, Canada
  2. 2.Single cell RNA sequencing for biomedical research
    Dave Tang, University of Western Australia, Australia
  3. 3.Clinical application of RNA sequencing
    Seung-Tae Lee, Yonsei University College of Medicine, Korea

Symposium 13

ANA standardization

Overview: ANA IFA pattern and interpretation and reporting vary among laboratories. The International Consensus of the ANA Pattern (ICAP) group has defined and classified the ANA IFA pattern. This workshop will introduce the processes and patterns of ICAP consensus, and will also review the status of ANA reporting in Korea.

Date & Time Sept. 27 (Fri), 15:00-16:40 Venue 201-202 (2F) Language English
Chairs Eun-Jee Oh, The Catholic University of Korea College of Medicine, Korea
Yunjung Cho, Korea University College of Medicine, Korea
Speakers
  1. 1.International Consensus on ANA pattern (ICAP): Nuclear patterns and their clinical relevance
    Luis E.C. Andrade, Federal University of Sao Paulo, Brazil
  2. 2.Cytoplasmic ICAP patterns and their clinical relevance
    Edward K.L. Chan, University of Florida, USA
  3. 3.Current status for ANA reporting in Korea
    Kyeong-Hee Kim, Dong-A University College of Medicine, Korea

Symposium 14

Laboratory Leadership

Overview: Leadership plays a critical role in establishing laboratory and impact the quality and rate at which the laboratory progresses over time. The environment and problems encountered in the clinical laboratory setting are unique, therefore leadership fine-tuned to the specific challenges of laboratory medicine is important. In this session, presentations on the leadership in laboratory medicine toward more effective strategies and practices inside and beyond the laboratory.

Date & Time Sept. 27 (Fri), 15:00-16:40 Venue 203-204 (2F) Language English
Chairs Young Kyung Lee, Hallym University College of Medicine, Korea
TBD
Speakers
  1. 1.Laboratory Leadership: A Critical Role Inside and Beyond the Laboratory
    Richard C. Friedberg, Baystate Medical Center, USA
  2. 2.Comparison of CAP and LMF Accreditation Programs – a Viewpoint from an Inspected Laboratory
    Sang Hoon Song, Seoul National University College of Medicine, Korea
  3. 3.Human Resouce Management
    Hwan Sub Lim, Seoul Clinical Laboratories, Korea

Keynote Speech 02

Date & Time Sept. 27 (Fri), 17:00-17:40 Venue 205 (2F) Language English
Chair Jin-Yeong Han, Dong-A University College of Medicine, Korea
Speaker
  1. Integration of genomics and artificial intelligence drives precision oncology
    Marilyn M. Li, University of Pennsylvania, USA

September 28 (Sat)

Keynote Speech 03

Date & Time Sept. 28 (Sat), 08:00-08:40 Venue 205 (2F) Language English
Chair Sun Hoe Koo, Chungnam National University College of Medicine, Korea
Speaker
  1. Integrated fever management: Disease severity markers to triage fever syndromes
    Kevin C. Kain, University of Toronto, Canada

Symposium 15

Education course for laboratory medicine specialist (* 지도 전문의 교육 세션)

Overview: This session is an essential education program to qualify as a laboratory medicine specialist. And the program covers the whole of the laboratory management, evaluation of resident training and laboratory information necessary for instruction of residents

Date & Time Sept. 28 (Sat), 08:00-12:00 Venue 101-103 (1F) Language Korean
Chairs Yong-Wha Lee, Soonchunhyang University College of Medicine, Korea
Myung Seo Kang, CHA University, Korea
Yoon Hwan Chang, Seoul National University College of Medicine, Korea
Jung-Sook Ha, Keimyung University School of Medicine, Korea
Speakers
  1. 1.Structure of medical cost in current insurance system
    Sang Gon Lee, Green Cross Laboratories, Korea
  2. 2.Principle and practice of quality control that the resident should know
    Sang-Guk Lee, Yonsei University College of Medicine, Korea
  3. 3.Real Experiences of the Laboratory Management to be heard to the Residents
    Sung-Eun Cho, LabGenomics Clinical Laboratories, Korea
  4. 4.Evaluation of Training Period for Laboratory Specialist
    Woo In Lee, Kyung Hee University School of Medicine, Korea
  5. 5.Online portfolio use in Training programs
    Jeong Su Park, Seoul National University College of Medicine, Korea
  6. 6.Preparing evaluation reports
    Dae-Hyun Ko, University of Ulsan College of Medicine, Korea
  7. 7.Useful websites for laboratory physicians (in the field of clinical genetics)
    Jieun Kim, Soonchunhyang University College of Medicine, Korea

Symposium 16

ESCMID-KSLM Session: Clinical microbiology: innovation in infectious disease

Overview: Infectious diseases represent an enormous human and economic burden to modern societies and currently contribute about 20% of the global annual death causes. To control infectious disease, the revolutionary diagnostic technologies such as culture-independent molecular detection assays, laboratory automation, point-of-care testing, and so on have been made available during the last 10 years in the clinical microbiology. In addition, the latest innovative diagnostic approaches applied in clinical microbiology will be introduced in this session.

Date & Time Sept. 28 (Sat), 09:00-10:40 Venue 205 (2F) Language English
Chairs Sunjoo Kim, Gyeongsang National University School of Medicine, Korea
Nam Yong Lee, Sungkyunkwan University School of Medicine, Korea
Speakers
  1. 1.A future perspective in clinical microbiology laboratories in Korea: Based on survey and focus group interview
    Chulhun L. Chang, Pusan National University School of Medicine, Korea
  2. 2.Multi-omics approaches: towards understanding host-microbiome interactions
    Lesley Hoyles, Nottingham Trent University, UK
  3. 3.Artificial Intelligence in Infectious Diseases
    Carolina Garcia-Vidal, Hospital Clinic de Barcelona, Spain

Symposium 17

Red cells: Transfusion & Technology

Overview: This session will focus on red cell technology and transfusion practice. Participants will learn about how monoclonal antibodies may act as inteferences with pretransfusion testing, how gene editing of erythroblasts may be used to enhance red cell transfusion compatibility, and how the red cells can be modified as quality control materials. In addition, listeners can learn about the latest guidelines of emergency and massive transfusion.

Date & Time Sept. 28 (Sat), 09:00-10:40 Venue 201-202 (2F) Language English
Chairs Dong-seok Jeon, Keimyung University School of Medicine, Korea
Chae Seung Lim, Korea University College of Medicine, Korea
Speakers
  1. 1.Monoclonal antibodies that interfere with pretransfusion testing
    Shyh-Chyi Lo, National Taiwan University Hospital, Taiwan
  2. 2.Enhancement of red blood cell transfusion compatibility using CRISPR-mediated erythroblast gene editing
    Ashley Toye, University of Bristol, UK
  3. 3.Using RBCs with modified blood group antigens as quality reagents
    Young Ae Lim, Ajou University School of Medicine, Korea
  4. 4.Standard operation manual for emergency and massive transfusion
    Duck Cho, Sungkyunkwan University School of Medicine, Korea

Plenary Lecture 03

Date & Time Sept. 28 (Sat), 11:00-12:00 Venue 205 (2F) Language English
Chair Hun-Suk Suh, Daegu Catholic University, Korea
Speaker
  1. Diagnostic stewardship, a new kid on the block
    Maurizio Sanguinetti, European Society of Clinical Microbiology and Infectious Diseases, Italy

Keynote Speech 04

Date & Time Sept. 28 (Sat), 13:00-13:40 Venue 205 (2F) Language English
Chair Junghan Song, Seoul National University College of Medicine, Korea
Speaker
  1. My Journey with “East Asian Paradox”: An Intriguing Story Through Laboratory Medicine Bridging to Patients
    Young-Hoon Jeong, Department of Internal Medicine, Gyeongsang National University College of Medicine, Korea

Symposium 18

CLSI standards: Application of innovative tests in clinical laboratories

Overview: In this session, CLSI standards on application of innovative tests in clinical laboratories will be presented including methods to validate and verify multiplex nucleic acid assays and methods for the identification of cultured microorganisms using MALDI-TOF MS, and defining and verifying reference intervals on big data.

Date & Time Sept. 28 (Sat), 14:00-15:40 Venue 205 (2F) Language English
Chairs Young Joo Cha, Chung-Ang University Hospital, Korea
Hee Jung Kang, Hallym University College of Medicine, Korea
Speakers
  1. 1.Validation and Verification of Multiplex Nucleic Acid Assays (MM17)
    Roberta M. Madej, RBM Consulting, LLC, USA
  2. 2.Methods for the identification of Cultured Microorganisms Using Matrix-Assisted Laser Desorption/ionization Time-of-Flight Mass Spectrometry (M58)
    Vera Tesic, University of Chicago Medicine, USA
  3. 3.A comparison of complete blood count reference intervals in healthy elderly vs. younger Korean adults: a large population study
    Miyoung Kim, Hallym University College of Medicine, Korea

Symposium 19

Advances in understanding and diagnosing hematologic disease

Overview: TBD

Date & Time Sept. 28 (Sat), 14:00-15:40 Venue 201-202 (2F) Language English
Chairs Myung-Geun Shin, Chonnam National University Medical School, Korea
Mina Hur, Konkuk University School of Medicine, Korea
Speakers
  1. 1.Thrombotic APS pathophysiology: Implications for laboratory diagnosis
    Katrien Devreese, Ghent University Hospital, Belgium
  2. 2.Advances in CBC analyzers: Newer parameters and their role in diagnostic hematology
    Parul Bhargava, University of California San Francisco, USA
  3. 3.Dilemma in assessment of plasma cell percentage in bone marrow based on IMW 2016 diagnostic criteria of multiple myeloma: How to measure plasma cell % and how to report?
    Dong Soon Lee, Seoul National University College of Medicine, Korea

Symposium 20

On-going innovations in Infection Control

Overview: TBD

Date & Time Sept. 28 (Sat), 13:40-15:40 Venue 101-103 (1F) Language Korean
Chairs Young Uh, Yonsei University Wonju College of Medicine, Korea
Mi-Kyung Lee, Chung-Ang University College of Medicine, Korea
Speakers
  1. 1.Probiotics for the prevention of healthcare-associated infection
    Dongeun Yong, Yonsei University College of Medicine, Korea
  2. 2.Precision medicine in antibiotics treatment
    Taek Soo Kim, Seoul National University Hospital, Korea
  3. 3.Decolonization of multidrug-resistant bacteria in patients
    Yangsoon Lee, Hanyang University College of Medicine, Korea
  4. 4.New disinfectants and technologies for improving disinfection of environmental surfaces in hospitals for infection control
    Kwang Sook Woo,Dong-A University College of Medicine, Korea
  5. 5.Changes in national classification of infectious diseases in 2020
    TBD